ANNA responds to EC consultation on OTC derivatives identifier for transparency purposes
Brussels, 9th January: ANNA and DSB have responded to the ECâs targeted consultation on selecting a unique product identifier for OTC derivatives transparency. ANNA and DSB highlighted their support for both the ISIN and UPI noting that the 2 standards…